Manuka, Inc. financial data

Symbol
MNKA on OTC
Industry
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Location
3 Eliezer Vardinon St., Petach Tikva, Israel
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Artemis Therapeutics, Inc. (to 5/18/2023), NEW YORK GLOBAL INNOVATIONS INC. (to 12/15/2016), INKSURE TECHNOLOGIES INC. (to 2/14/2014), INKSURE TECHNOLOGIES INC (to 3/30/2005), LIL MARC INC (to 11/25/2002)
Latest financial report
Q3 2023 - Nov 21, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12.2 % -78.4%
Quick Ratio 5.6 %
Debt-to-equity -120 % +62.1%
Return On Equity 92.8 % -80.1%
Return On Assets -466 % -65.3%
Operating Margin -176 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 112M shares
Common Stock, Shares, Outstanding 112M shares +0.82%
Entity Public Float 169M USD -99.5%
Common Stock, Value, Issued 1.12M USD +0.81%
Weighted Average Number of Shares Outstanding, Basic 112M shares +114%
Weighted Average Number of Shares Outstanding, Diluted 112M shares +114%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 671K USD +49.2%
Cost of Revenue 80K USD +125%
Selling and Marketing Expense 732K USD -56.9%
General and Administrative Expense 1.04M USD +51.9%
Operating Income (Loss) -1.18M USD -16.1%
Nonoperating Income (Expense) 42K USD +2400%
Net Income (Loss) Attributable to Parent -1.14M USD -11.3%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1K USD -98.8%
Accounts Receivable, after Allowance for Credit Loss, Current 15K USD -28.6%
Inventory, Net 104K USD +57.6%
Assets, Current 128K USD -42.9%
Property, Plant and Equipment, Net 40K USD -25.9%
Operating Lease, Right-of-Use Asset 27K USD -41.9%
Intangible Assets, Net (Excluding Goodwill) 32K USD -11.1%
Assets 200K USD -43.8%
Accounts Payable, Current 358K USD
Accrued Liabilities, Current 333K USD +25.7%
Liabilities, Current 1.24M USD +72.6%
Operating Lease, Liability, Noncurrent 5K USD -79.9%
Other Liabilities, Noncurrent 34K USD -2.86%
Liabilities 1.59M USD +58.2%
Retained Earnings (Accumulated Deficit) -3M USD -62.2%
Stockholders' Equity Attributable to Parent -1.39M USD -114%
Liabilities and Equity 200K USD -43.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -96K USD +38.9%
Net Cash Provided by (Used in) Financing Activities 150K USD +1054%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 112M shares +0.82%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1K USD -98.8%
Deferred Tax Assets, Valuation Allowance 335K USD +294%
Deferred Tax Assets, Gross 335K USD +294%
Operating Lease, Liability 24K USD -44%
Depreciation 4K USD +100%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 25K USD -46.7%
Property, Plant and Equipment, Gross 66K USD +65%
Operating Lease, Liability, Current 19K USD +5.47%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -75.3%
Deferred Tax Assets, Operating Loss Carryforwards 1.46M USD +303%
Additional Paid in Capital 0 USD -100%
Depreciation, Depletion and Amortization 16K USD +433%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 65K USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares